Product Recall of Antihistamine Drugs Due to Heartburn Contamination Risk
Details of the Recall
A significant product recall is currently affecting antihistamine medications across the U.S. due to possible contamination with a heartburn drug. According to the FDA, Unique Pharmaceutical Laboratories is voluntarily recalling cetirizine hydrochloride tablets due to risks associated with ranitidine.
Reasons for the Recall
On July 18, a pharmacy technician noticed discoloration and red dots on some of the tablets during handling. The FDA has warned that consumers sensitive to ranitidine could face severe reactions, including hypotension and respiratory issues.
Affected Products
- Tablets under recall are packaged in 100-tablet bottles.
- Lot numbers affected include: GY825029, GY825030, GY825031, GY825032.
Consumer Guidance
Rising Pharma Holdings has reached out to retailers for the return of affected products. Consumers are advised to contact Rising Pharma for further information and should consult healthcare providers if they encounter health problems.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.